Raf Bisschops, MD, PhD (University Hospitals Leuven, Belgium)
University Hospitals Leuven
University Hospitals Leuven
Raf
Bisschops obtained his Medical Degree in
1997 ,a PhD degree and certification in
gastroenterology in 2005 at the University of Leuven. He is associate head of clinic and associate professor at the Catholic
University of Leuven (KU Leuven), faculty of medicine. He is director of
endoscopy since 2013. His main interest is advanced endoscopic imaging and
therapeutics for premalignant conditions (Barrett, HNPCC, colitis) and quality
in endoscopy. He is co-editor of the
journal Endoscopy, president of the Belgian society of Gastrointestinal
endoscopy, chairman of the quality committee, chairman of the curriculum
working group and councilor in the boardof the European Society of Gastrointestinal
endoscopy.
Karolien Boeren, MD (AZ Delta, Roeselare, Belgium)
AZ Delta, Roeselare
AZ Delta, Roeselare
Dr. Karolien Boeren is currently staff member of the Radiology
Department of AZ Delta Hospital in Roeselare, Belgium. She works as a general
radiologist with a special focus on abdominal radiology, in particular on
imaging in Crohn’s disease – MR enterography.
Karolien graduated in medicine from the University of Leuven in 2009.
She then underwent specialization in radiology (2014). During her
specialization she did an supplementary scholarship in abdominal radiology in
the AMC hospital in Amsterdam.
Anneline Cremer, MD, PhD (Hôpital Erasme ULB, Bruxelles, Belgium)
Hôpital Erasme ULB, Bruxelles
Hôpital Erasme ULB, Bruxelles
Anneline Cremer graduated
from the Université Libre de Bruxelles (ULB) medical school, Belgium, in 2010.
She graduated from the Erasme academic Hospital, ULB, Belgium, in
Gastroenterology in 2017 with summa cum laude. Her strong
interest for Gastroenterology and more specifically for Inflammatory Bowel
Disease (IBD) has grown over the years.
During her
last year in medical school, she spent 6 months in the Laboratory of
Experimental Gastroenterology (LGE), ULB, in Brussels working on a basic immunology
project. She started her clinical training in 2010, and started her
Gastroenterology training in October 2013 in the Department of Gastroenterology
of Tivoli Hospital (La Louvière) for six months followed by one year and a half
in the Department of Gastroenterology of ULB-Erasme Hospital. She
received a doctoral research fellowship (October 2015-April 2020) from
the Fonds Erasme (ULB).
She also participated as co-investigator in clinical
trials in the field of Crohn's Disease and Ulcerative Colitis since November
2015. She is currently working half time in clinic in the
Department of Gastroenterology of ULB-Erasme Hospital
and half time in the LGE on a translational IBD research project
under
supervision of Prof Denis Franchimont.
André D'Hoore, MD, PhD (University Hospitals Leuven, Belgium)
University Hospitals Leuven
University Hospitals Leuven
D’Hoore André graduated as MD at the Catholic
University of Leuven, Belgium in 1988. He became surgeon in 1994 and joined the
staff of Abdominal Surgery at the University Clinic Leuven. He received an
international postgraduate training in colorectal surgery at the Cleveland
Clinic in Fort Lauderdale, St. Mark’s Hospital
in London and the Hôpital Cantonal in Geneva.
In 2000 he became a European Board Qualified Surgeon
in ColoProctology. In 2007 he obtained his PhD and is full professor at the
Faculty of Medicine, Catholic University of Leuven and contributes to graduate
an postgraduate teaching of students and trainees in abdominal surgery.
He is the actual chair of the department of abdominal
surgery at the University Hospitals Leuven and is the president of the
Collegium Chirurgicum Belgicum.
Recently he received the honorary membership of the
American and Mexican Society of Colorectal Surgery.
André D’Hoore is a regular invited speaker at
international surgical meetings. His scientific work resulted in more than 200
peer-reviewed papers.
He is a founding member of the European Section of
Coloproctology (ESCP) and is the founder of the surgical branch of the European
Crohn’s and Colitis Organisation (S-ECCO).
Nicolas De Suray, MD (Grand Hôpital de Charleroi/Cliniques Universitaires Saint-Luc, Bruxelles, Belgium)
Grand Hôpital de Charleroi/Cliniques Universitaires Saint-Luc, Bruxelles
Grand Hôpital de Charleroi/Cliniques Universitaires Saint-Luc, Bruxelles
Nicolas de Suray is gastroenterologist at
Saint-Joseph’s Hospital in Charleroi, and consultant in the IBD unit at
Saint-Luc University Hospital in Brussels. He obtained his MD in 2003 and a
master in gastroenterology in 2009 at UCLouvain. In 2007-2008, he spend one
year in France at Claude Huriez Hospital, Centre Hospitalier Régional
Universitaire of Lille, in the IBD unit as a fellow of Professor Jean-Frédéric
Colombel. Between 2010 and 2012, he was consultant in the IBD unit of Lille. He
is a member of ECCO and of the Belgian IBD Research Group. He is actively
involved in several clinical trials and clinical researchs in IBD.
Bénédicte De Vroey, MD (CH Jolimont, Haine-Saint-Paul, Belgium)
CH Jolimont, Haine-Saint-Paul
CH Jolimont, Haine-Saint-Paul
Bénédicte De Vroey is Gastroenterologist at the CH Jolimont,
Haine-Saint-Paul, Belgium, with particular interest in inflammatory bowel
disease (IBD). She is also IBD-consultant at Cliniques Universitaires
Saint-Luc, Brussels, Belgium. She graduated in Medicine from the Université
Catholique of Louvain, Belgium, in 2006, and completed her Masters degree in
Gastroenterology in the same institutions. She also made a one-year IBD
fellowship in the Centre Hospitalier Régional Universitaire of Lille, France,
in 2010, under the supervision of Professor Jean-Frédéric Colombel. She is
author or co-author of several publications in the fields of general
gastroenterology and IBD, co-investigator in clinical research, and
co-investigator of ongoing international collaborative research projects looking
at the epidemiology of IBD.
Stefan Delen, MD (Ziekenhuis Maas en Kempen, Maaseik, Belgium)
Ziekenhuis Maas en Kempen, Maaseik
Ziekenhuis Maas en Kempen, Maaseik
Stefan Delen
(1974) graduated at KU Leuven as Medical Doctor in 1999 and as
gastroenterologist in 2005.
He is head
of the department of Gastroenterology of Ziekenhuis Maas en Kempen in Maaseik
where he is working since 2005. In this hospital he is also head of the
internal day care clinic and vice –president of the medical council. He focuses mainly on inflammatory bowel disease (IBD)
and digestive oncology.
Since 2010
until today he is also consultant at the IBD outpatient clinic of the
university hospital of Leuven.
Olivier Dewit, MD, PhD (Cliniques Universitaires Saint-Luc, Bruxelles, Belgium)
Cliniques Universitaires Saint-Luc, Bruxelles
Cliniques Universitaires Saint-Luc, Bruxelles
Specialist in Gastroenterology since September 2000. Head of the IBD clinic and Deputy Chief of the gastroenterology unit at Cliniques Universitaires Saint Luc, Brussels. Thesis in biomedical sciences in 2012. In charge of the Gastroenterology cursus in Master 1 of Medicine at UCL Louvain.Scientific advisor for colorectal diseases and member of the board of the "Royal Belgian Society of Gastroenterology". President of the medical and scientific committee of the Belgian French-speaking IBD patients association. BIRD Member since 1999 and actual member of EDUCOM. Member of GETAID (Groupe d’étude thérapeutique des affections Inflammatoires du tube digestif) since 2006. Author or co-author of over 70 articles or book chapters.
Peter Irving, MA MD FRCP (Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom)
Guy’s and St Thomas’ NHS Foundation Trust, London
Guy’s and St Thomas’ NHS Foundation Trust, London
Peter Irving is lead for IBD at Guy’s and St Thomas’
Hospital Foundation Trust in London and is an Honorary Reader at King’s College
London funded by an MRC Clinical Academic Research Partenship award. Dr Irving
trained in medicine at Cambridge University and The London Hospital Medical
College, UK. He trained in gastroenterology in London before undertaking an IBD
fellowship in Melbourne, Australia. He has a large IBD practice and a number of
active research interests in clinical IBD and trials. He has published widely
in IBD including several books, book chapters and over 130 peer-reviewed
articles. He was the Chair of the Education Committee of ECCO from 2016-2018
and is now the ECCO e-learning ambassador.
Triana Lobaton, MD, PhD (UZ Gent, Belgium)
UZ Gent
UZ Gent
Triana
Lobatón finished her training as gastroenterologist at Bellvitge
University Hospital (Barcelona, Spain) in 2010. During her training, she spent
2 moths at Mount Sinai University Hospital in NY (US). She obtained her
PhD on "fecal calprotectin as a surrogate
marker of disease activity in IBD patients" at the University
of Barcelona in 2015.
As part of her PhD program, she spent 18 months
(2013-2014) at Leuven University Hospital (Belgium)under the supervision of
Prof. Séverine Vermeire.
Her clinical activity and research is
focused on IBD, in particular clinical projects. She has been
coordinator of the young GETECCU (Spanish group of Crohn and Colitis),
and is also involved in several ECCO activities such as the e-courses
or editor for the ECCO 2019 Medicom Conference Report.
Since December 2017 Dr.Lobaton is working as a full time
staff member at the IBD Unit of the Department of
Gastroenterology at Ghent University Hospital (UZ Gent). The IBD unit
at UZ Gent is a tertiary referral center involved in many RCTs, being
Dr. Lobaton PI of many of them.
Edouard Louis, MD, PhD (CHU Liège, Belgium)
CHU Liège
CHU Liège
Edouard LOUIS has been Professor of
Gastroenterology and Head of the Gastroenterology department at Liège University
hospital since October 2010. His Scientific work contributed to more than 280
papers in international journals (H-Index 2018=63). He has been General
Secretary of the Belgian Society of Gastroenterology 2005-2009, President of
the Belgian IBD Research group (2008-2011), member of the Scientific Committee
of the ECCO (European Crohn and Colitis Organisation) (2010-2013) and Chair of
this Scientific Committee (2013-2015). He has been member of the board of the
GETAID (groupe d’étude thérapeutique des affections inflammatoires digestives)
(2004-ongoing), president and vice-president of the GETAID (2012-2015 and
2015-2018). He is Associate Editor of Journal of Crohn’s and Colitis
(2018-ongoing).
Harald Peeters, MD, PhD (AZ Sint-Lucas, Gent, Belgium)
AZ Sint-Lucas, Gent
AZ Sint-Lucas, Gent
Harald
Peeters is a gastroenterologist in the hospital AZ Sint-Lucas in Gent and
part-time associate professor at Ghent
University. His main interests are IBD and therapeutic endoscopy. He is a
member of BIRD (Educom) and ECCO. In the Sint-Lucas IBD clinic he is involved
in national and international clinical trials in IBD. He is reviewer for
several international peer-reviewed journals as well as for ECCO and UEGW
abstracts.
Jean-François Rahier, MD, PhD (CHU UCL Namur, Belgium)
CHU UCL Namur
CHU UCL Namur
Jean-François Rahier was born in Belgium
in 1975. He obtained his diploma of medical doctor with cum laude in 2000 from the University of Louvain (UCL) and
specialized in Gastroenterology in 2007. He was first trained by Pr O Dewit in
Cliniques Universitaires Saint Luc in 2005 and then by Pr JF Colombel in Lille
in 2006-2007. Besides, he had a part-time research activity in 2008-2013 at the
INSERM U995 laboratory of Professor Desreumaux in Lille (France) where he
obtained his PhD on “lymphangiogenesis in IBD” in 2014.
He is working at the
University Hospital CHU UCL Namur in Belgium where his clinical activity is
focused on inflammatory bowel disease (IBD) and also acted between 2014 and
2018 as consultant for phase II-III clinical trials in CHU Liège (Pr E Louis).
In 2009 and 2014, he was the leading author for the European consensus on
management and prevention of opportunistic infection in IBD. He has authored or
co-authored around 50 peer-reviewed manuscript and is part of the scientific
and executive committee of I-CARE. He is an active member of the Belgian IBD
Group where he acts as President since 2017, of the European Crohn's and
Colitis Organisation and of the GETAID (France).
Gerhard Rogler, MD, PhD (University Hospital Zürich, Switzerland)
University Hospital Zürich, Switserland
University Hospital Zürich, Switserland
Professor Gerhard
Rogler, MD, is Professor of Gastroenterology and Hepatology and Head of the
Department of Gastroenterology & Hepatology, Zürich University Hospital,
Switzerland.
The main research
interest of Professor Rogler is translational research to better understand the
unmet needs in the IBD field, especially in terms of intestinal stricture and
fistula formation. His research group has developed new models for intestinal
fibrosis and achieved a novel understanding of fistula pathophysiology. He is
PI of the Swiss IBD Cohort Study, member of the ECCO governing board and member
of the IOIBD. Professor Rogler has authored over 500 peer-reviewed articles.
Dirk Staessen, MD (GZA Ziekenhuizen, Antwerpen, Belgium)
GZA Ziekenhuizen, Antwerpen
GZA Ziekenhuizen, Antwerpen
Dirk Staessen
graduated as MD in 1981 at KU Leuven and completed his training in internal
medicine and gastroenterology in 1987 at UZ Gasthuisberg in Leuven.
Since 1987 he started
working as gastroenterologist in AZ Monica , Antwerpen, and joined the
gastroenterology department of the GZA Ziekenhuizen , Antwerpen, in 2011.
As member of BIRD and
ECCO he developed a special interest in IBD and is actively involved in
IBD clinical trials.
Catherine Van Kemseke, MD, PhD (CHU Liège, Belgium)
CHU Liège
CHU Liège
Catherine
Van Kemseke is Professor of Clinic and Head of Clinic in the Gastroenterology
Department in the University Hospital of Liège.
She
completed her medical doctorate and her specialist training in the University
of Liège till 1998. She obtained a Ph.D. in medical sciences in 2002 with a
thesis on serologic markers in Crohn’s disease.
She is part
of several scientific associations including the SRBGE (Société Royale Belge de
Gastroentérologie), the BIRD (Belgian Intestinal Research and Development
group) and the SNFCP (Société Nationale Française de Coloproctologie).
She is for
the third year the General Secretary of SRBGE and she occupies the position of
President of French Gastroenterology Commission Agreement.
Her main
centres of interest are proctology and inflammatory bowel diseases. For this
part, she is working in the IMID Centre with Professor Edouard Louis.
Stijn Vanden Branden, MD (Onze-Lieve-Vrouwziekenhuis Aalst, Belgium)
Onze-Lieve-Vrouwziekenhuis Aalst
Onze-Lieve-Vrouwziekenhuis Aalst
Dr. Stijn Vanden Branden graduated
as MD at the Vrije Universiteit Brussel in 2002.
He qualified as a
gastroenterologist in 2008.
Since 2009 he serves as a full
staff member at the OLV Hospital
in Aalst.
His interest is in inflammatory bowel disease (IBD) and esophageal and anal manometry.
He spent 6 months as a consultant in the IBD outpatient clinic at the
University Hospital Gasthuisberg UZ Leuven to obtain additional expertise in
this specific field of Inflammatory Bowel Disease.
He is member of BIRD, ECCO and VVGE.
Stephanie Verschuere, MD, PhD (AZ Delta, Roeselare, Belgium)
AZ Delta, Roeselare
AZ Delta, Roeselare
Stephanie Verschuere graduated as
a medical doctor in 2005 at Ghent University. In 2012, she obtained a PhD on
the subject of the effect of cigarette smoke on mucosal immunity of the
terminal ileum. She graduated in 2014 as a pathologist after an internship in
UZ Gent and AZ Sint Jan Brugge.
After a residency in AZ sint Jan Brugge, she
started working as pathologist in AZ Delta and Sint Andries Tielt in 2016, with
special interest in the pathology of the gastrointestinal tract and in
urological pathology. She is an active member of several national pathology
working groups. Since 2017, she participates in the multidisciplinary team
meetings IBD at AZ Delta.
Bram Verstockt, MD, PhD (University Hospitals Leuven, Belgium)
University Hospitals Leuven
University Hospitals Leuven
Bram Verstockt (° 09/01/1988), MD, PhD, graduated medical school at the KU Leuven, Belgium, in 2013. During his medical training, he performed an internship at the Mater Dei Hospital, Malta. Under the supervision of prof. W. Peetermans, he started his specialist training in Internal Medicine in 2013. In 2015, he partially interrupted his residency in Gastroenterology and Hepatology to start his PhD ‘Predicting outcome in inflammatory bowel diseases, a multi-omics approach – Creating opportunities for personalised medicine’, which he successfully defended in September 2019. During the first year of his PhD he worked at the University of Cambridge, United Kingdom in the lab of Ken smith.
His research mainly focusses on the development of predictive and prognostic markers for a more personalised medicine in IBD. He held a PhD fellowship at the Flemish Foundation for Scientific Research (FWO Vlaanderen) and received research grants from the European Crohn’s and Colitis organisation (ECCO), the Helmsley foundation, the Belgian Inflammatory Bowel Disease Research and Development Group (BIRD), the Belgian Week of Gastroenterology (BWGE) and the Flemish Association for Crohn and Colitis patients (CCV VZW). Currently he finishes his residency in Gastroenterology and Hepatology at the University Hospitals Leuven.
Barbara Willandt, MD (AZ Sint-Jan, Brugge, Belgium)
AZ Sint-Jan, Brugge
AZ Sint-Jan, Brugge
Willandt
Barbara graduated as medical doctor at theuniversity of Leuven in 2009 and subsequently completed her master in gastroenterology
in 2015. Because of a specific interest in the multidisciplinary IBD care she completed
an additional fellowship in inflammatoy bowel disease at the
University Hospital of UZ Leuven in 2016. She is currently working as
a staff member in AZ Sint Jan Brugge since August 2016 where she mainly focuses
on IBD-care and also continues to work as a consultant at the
IBD outpatient clinic of the university hospital of Leuven. She is a member of
several scientific associations such as BIRD, ECCO, ESGE and VVGE.
